| Literature DB >> 29580152 |
Jaya Devi Chidambaram1, Namperumalsamy Venkatesh Prajna2,3, Palepu Srikanthi2, Shruti Lanjewar2, Manisha Shah2,3, Shanmugam Elakkiya2,3, Prajna Lalitha2,3, Matthew J Burton1,4.
Abstract
PURPOSE: Here, we report risk factors associated with outcome in severe bacterial keratitis (BK), fungal keratitis (FK), and Acanthamoeba keratitis (AK) in India.Entities:
Keywords: Acanthamoeba; India; Streptococcus pneumoniae; aspergillus; blindness; corneal ulcer; epidemiology; fungi; fusarium; microbial keratitis
Mesh:
Substances:
Year: 2018 PMID: 29580152 PMCID: PMC5985925 DOI: 10.1080/09286586.2018.1454964
Source DB: PubMed Journal: Ophthalmic Epidemiol ISSN: 0928-6586 Impact factor: 1.648
Socio-demographic and clinical risk factors associated with bacterial, fungal, and Acanthamoeba keratitis at presentation.
| Risk factor | All microbial keratitis | Bacterial keratitis | Fungal keratitis | No organism | ||
|---|---|---|---|---|---|---|
| Age, years (median, IQR) | 50 (37–60) | 60 (35–65) | 50 (36–58) | 39 (34–55) | 53 (43–61) | 0.066 |
| Gender (% male) | 162 (64) | 12 (63) | 123 (64) | 11 (61) | 13 (65) | 0.993 |
| Occupation: no. agricultural workers (%) | 159/251 (63) | 15 (79) | 121 (64) | 11 (61) | 10 (50) | 0.311 |
| Had primary education or greater (%) | 135/246 (55) | 8 (42) | 107/186 (57) | 9/17 (53) | 10 (50) | 0.577 |
| Current tobacco use (%) | 34/234 (14) | 4/16 (25) | 23/178 (13) | 1 (6) | 6/18 (33) | 0.047 |
| Symptom duration before presentation to AEH, days (median, range) | 7 (5–15) | 9 (5–15) | 7 (4–11) | 30 (20–60) | 10 (7–21) | <0.001 |
| Symptom duration before presentation to any healthcare provider (HCP), days (median, range) | 2 (0–3) | 2 (0.5–5) | 2 (0–3) | 2 (0–7) | 0 (0–3) | 0.547 |
| History of eye trauma (%) | 181 (72) | 13 (68) | 134 (70) | 13 (72) | 17 (85) | 0.563 |
| Trauma with vegetative matter (%) | 82/251 (33) | 10/13 (77) | 56/133 (42) | 3/13 (23) | 9/17 (53) | 0.033 |
| Prior antifungal use (%) | 125/220 (57) | 7/16 (44) | 98/169 (58) | 10 (59) | 8/15 (53) | 0.727 |
| Prior antibiotic use | 162/220 (74%) | 11/16 (69%) | 123/169 (73%) | 14/17 (82%) | 11/15 (71%) | 0.825 |
| Prior steroid use (%) | 25/220 (11) | 1/16 (6) | 16/169 (9) | 7/17 (41) | 1/15 (7) | 0.001 |
| Traditional medicine use (%) | 48 (19) | 4 (21) | 37 (19) | 5 (28) | 2 (10) | 0.578 |
| Plant-based traditional medicine used (%) | 21/47 (45) | 2/4 (50) | 15/36 (42) | 3/5 (60) | 1/2 (50) | 0.879 |
| Prior MK in affected eye (%) | 9 (4) | 1 (5) | 8 (4) | 0 (0) | 0 (0) | 0.627 |
| Diabetes mellitus (%) | 17 (7) | 0 (0) | 15 (8) | 0 (0) | 1 (5) | 0.356 |
| Stromal infiltrate size, mm2 (median, IQR) | 4.5 (3.5–5.9) | 3.9 (3.2–6.1) | 4.5 (3.3–5.5) | 6.8 (5.3–8.0) | 5.2 (4.0–6.1) | <0.001 |
| Posterior 1/3 of cornea affected at presentation (%) | 168/251 (67) | 14 (74) | 123 (64) | 12 (71) | 17 (85) | 0.261 |
| Entropion, Ectropion, or lagophthalmos present (%) | 12 (5) | 2 (10) | 8 (4) | 0 (0) | 2 (10) | 0.310 |
| Blocked tear duct (%) | 19 (7) | 4 (21) | 12 (6) | 0 (0) | 3 (15) | 0.039 |
*Bacterial, fungal, and Acanthamoeba groups compared for statistically significant differences using chi-square test (for proportions) or Kruskal–Wallis test (non-parametrically distributed variables).
Proportion of study participants with mild, moderate, or severe visual impairment (VI) or blindness in affected eye at presentation and at final visit, as per the World Health Organization criteria.
| Risk factor | Totals (%) | Bacterial keratitis (BK) (%) | Fungal keratitis (FK) (%) | No organism (%) | ||
|---|---|---|---|---|---|---|
| Normal (<6/9) | 22 (9) | 1 (5) | 19 (10) | 1 (6) | 1 (5) | 0.773 |
| Mild VI (6/9 to 6/18) | 24 (10) | 1 (5) | 21 (11) | 0 (0) | 2 (10) | 0.468 |
| Moderate VI (>6/18 to 6/60) | 35 (14) | 2 (10) | 31 (16) | 1 (6) | 1 (5) | 0.369 |
| Severe VI (>6/60 to 3/60) | 139 (57) | 13 (68) | 102 (54) | 11 (69) | 13 (65) | 0.370 |
| Blind (>3/60) | 24 (10) | 2 (10) | 16 (8) | 3 (19) | 3 (15) | 0.485 |
| - | ||||||
| Normal | 32 (14) | 0 (0) | 30 (16) | 2 (11) | 0.155 | |
| Mild VI | 43 (19) | 3 (17) | 36 (19) | - | 4 (22) | 0.915 |
| Moderate VI | 34 (15) | 2 (11) | 28 (15) | - | 4 (22) | 0.641 |
| Severe VI | 76 (34) | 7 (39) | 65 (35) | - | 4 (22) | 0.489 |
| Blind | 36 (16) | 6 (33) | 26 (14) | - | 4 (22) | 0.413 |
*Proportion of BK, FK, and AK groups within each visual acuity category compared with all others for statistically significant differences using chi-square test.
Clinical features in bacterial, fungal, and Acanthamoeba keratitis at presentation.
| Ulcer appearance | Bacterial keratitis, BK ( | Fungal keratitis, FK ( | ||
|---|---|---|---|---|
| Feathery margin | 5 (26) | 134 (70) | 2 (11) | <0.001 |
| Raised profile | 3 (16) | 48 (25) | 0 (0) | 0.039 |
| Dry texture of slough | 1 (5) | 77 (40) | 5 (28) | 0.007 |
| Satellite lesions | 5 (26) | 70 (37) | 2 (11) | 0.070 |
| Non-yellow infiltrate | 12 (63) | 141 (74) | 16 (89) | 0.197 |
| Pigmented ulcer | 0 (0) | 9 (5) | 0 (0) | 0.404 |
| Ring infiltrate | 8 (42) | 54 (28) | 16 (89) | <0.001 |
| Perineural infiltrate | 0 (0) | 1 (0.5) | 1 (6) | 0.083 |
| Corneal neovascularization | 5 (26) | 22 (11) | 3 (17) | 0.172 |
| DM folds | 6 (32) | 94 (49) | 6 (33) | 0.172 |
| Endothelial plaque | 10 (53) | 75 (39) | 4 (22) | 0.164 |
| Hypopyon | 17 (89) | 120 (63) | 6 (33) | 0.002 |
| Cells and/or flare in AC | 11/12 (92) | 102/148 (69) | 6/12 (50) | 0.085 |
| Keratic precipitates | 6 (32) | 55/183 (30) | 4/16 (25) | 0.900 |
*Comparison of all three groups (BK, FK, and AK) to assess for statistically significant differences using chi square test.
Risk factors associated with clinical outcomes in severe microbial keratitis (*groups compared with chi-square test for proportions and Kruskal–Wallis for continuous non-parametrically distributed variables).
| Outcome risk factor | Worse ( | Good ( | |
|---|---|---|---|
| Age, years (median, IQR) | 53 (40–60) | 45 (35–57) | 0.036 |
| Gender (no. male, %) | 68 (58) | 79 (71) | 0.031 |
| Occupation: agricultural (%) | 82 (70) | 62/109 (57) | 0.039 |
| Primary education or more (%) | 53 (46) | 69 (65) | 0.004 |
| Current smoker/tobacco use (%) | 14 (13) | 18 (17) | 0.392 |
| Symptom duration, days (median, range) | 9 (5–15) | 7 (4–10) | <0.001 |
| Any eye trauma (%) | 84 (72) | 80 (73) | 0.875 |
| Trauma with vegetative matter (%) | 44 (38) | 32/109 (29) | 0.190 |
| Prior antifungal use (%) | 61/102 (60) | 50/94 (53) | 0.351 |
| Prior antibiotic use (%) | 77 (75) | 64 (68) | 0.249 |
| Prior steroid use (%) | 9 (9) | 8 (8) | 0.938 |
| Traditional medicine use (%) | 20 (17) | 22 (20) | 0.573 |
| Plant based (%) | 7/19 (37) | 10/22 (45) | 0.577 |
| Seen by another healthcare provider first (%) | 103 (88) | 98 (89) | 0.803 |
| Prior microbial keratitis (%) | 6 (5) | 3 (3) | 0.354 |
| Diabetes mellitus (%) | 12 (10) | 4 (4) | 0.051 |
| Best-corrected visual acuity-affected eye (median logMAR, IQR) | 1.8 (1.7–1.8) | 1.7 (0.46–1.8) | <0.001 |
| Stromal infiltrate size, mm2 (median, IQR) | 5.2 (4.0–6.5) | 3.8 (3.1–4.7) | <0.001 |
| Posterior 1/3 of cornea involved ( | 94 (80) | 58 (53) | <0.001 |
| Presence of hypopyon (%) | 86 (74) | 61 (55) | 0.004 |
| Bacteria (excluding mixed BK/FK) (%) | 10 (9) | 8 (7) | 0.695 |
| 7 (7) | 2 (2) | 0.108 | |
| Fungi (excluding mixed BK/FK) (%) | 95 (86) | 91 (84) | 0.661 |
| 28 (24) | 46 (42) | 0.004 | |
| 22 (19) | 8 (7) | 0.010 |
Univariate and multivariate logistic regression analyses of risk factors associated with worse outcome in severe microbial keratitis (*adjusted for age and gender).
| Risk factor | Univariable OR* (95% CI) | Multivariable OR (95% CI) | ||
|---|---|---|---|---|
| Age | 1.09 (1.00–1.04) | 0.048 | 0.99 (0.97–1.01) | 0.539 |
| Female gender | 1.84 (1.05–3.20) | 0.032 | 2.04 (1.03–4.04) | 0.040 |
| Presenting ulcer infiltrate size (mm2) | 1.80 (1.45–2.23) | <0.001 | 1.63 (1.30–2.05) | <0.001 |
| 2.87 (1.19–6.88) | 0.018 | 3.23 (1.26–8.25) | 0.014 | |
| Posterior corneal involvement | 3.33 (1.82–6.11) | <0.001 | 2.31 (1.16–4.59) | 0.017 |
| No formal education | 1.68 (0.92–3.05) | 0.089 | 2.30 (1.14–4.62) | 0.019 |
| Symptom duration (days) | 1.07 (1.03–1.12) | 0.001 | 1.05 (1.00–1.10) | 0.032 |
| Vegetative trauma | 1.68 (0.94–3.02) | 0.079 | - | - |
Organisms identified by culture, light microscopy, and in vivo confocal microscopy by clinical outcome.
| Organisms | Perforated or glued ( | Worse ( | Improving ( | Healed ( |
|---|---|---|---|---|
| 4 | 2 | 1 | 1 | |
| 1 | 0 | 0 | 0 | |
| 0 | 1 | 0 | 0 | |
| 0 | 0 | 2 | 1 | |
| 1 | 1 | 0 | 2 | |
| 0 | 0 | 1 | 0 | |
| 7 | 20 | 7 | 1 | |
| 13 | 15 | 25 | 21 | |
| 0 | 0 | 1 | 0 | |
| 0 | 0 | 1 | 0 | |
| 0 | 1 | 2 | 1 | |
| 1 | 1 | 0 | 0 | |
| 2 | 2 | 0 | 1 | |
| 0 | 1 | 1 | 0 | |
| Unidentified hyaline fungi | 1 | 10 | 4 | 0 |
| Unidentified dematiaceous fungi | 2 | 3 | 5 | 1 |
| Light microscopy positive for fungi, culture negative | 5 | 7 | 10 | 5 |
| Light microscopy and culture negative for fungi, but IVCM positive for fungi | 1 | 3 | 3 | 2 |
| 1 | 0 | 0 | 0 | |
| 0 | 1 | 1 | 0 | |
| 0 | 1 | 0 | 0 | |
| Light microscopy, culture, and IVCM negative for any organism | 3 | 6 | 6 | 4 |
*Mixed infections were culture positive for bacteria (species shown in table) and also positive for fungi detected only in light microscopy and/or in vivo confocal microscopy.